(Q48388675)

11 February 2018

http://europepmc.org/abstract/MED/24322174

title

SIRT3 expression as a biomarker for better prognosis in gastric cancer (English)

1 reference

11 February 2018

http://europepmc.org/abstract/MED/24322174

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hsin-Chen Lee

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Kuo-Hung Huang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Wen-Liang Fang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Chin-Wen Chi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ming-Ta Sung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Hwa-Li Kao

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Anna Fen-Yau Li

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Pen-Hui Yin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Muh-Hwa Yang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

1 April 2014

1 reference

11 February 2018

http://europepmc.org/abstract/MED/24322174

published in

World Journal of Surgery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

910-917

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Sirtuins--novel therapeutic targets to treat age-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric Restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Altered sirtuin expression is associated with node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Low SIRT3 expression correlates with poor differentiation and unfavorable prognosis in primary hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Gastric carcinoma. A pathobiological classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-013-2359-0

Nodal dissection for patients with gastric cancer: a randomised controlled trial

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24322174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

SIRT3 and cancer: tumor promoter or suppressor?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24322174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00268-013-2359-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24322174%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference